EVALUATE ENTERIC-COATED CYSTEAMINE THERAPY IN PATIENTS WITH CYSTINOSIS

评估肠溶半胱胺治疗胱氨酸中毒患者的疗效

• 批准号: 8166815
• 负责人: Ranjan Dohil
• 金额: $ 0.1万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8166815
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Cystagon; Cysteamine; Cystinosis; Dose; Enteral; Frequencies; Funding; Grant; Institution; Patients; Research; Research Personnel; Resources; Source; United States National Institutes of Health; capsule

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine whether dose frequency can be reduced giving enteric coated cystagon capsules.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 确定是否可以降低剂量频率，从而给肠涂有覆盖的甲状腺囊胶囊。